Table 2.
top plateau; 95% CI [lower-higher] |
||
---|---|---|
without albumin | with albumin | |
IgA1 | 49% [45–54%] | 47% [44–50%] |
IgA1-LCABD | 57% [54–60%] | 52% [49–54%] |
IgA1-HCABD | 51% [49–53%] | 23% [21–24%] |
IgA2 | 44% [41–47%] | 46% [43–50%] |
IgA2-LCABD | 40% [34–40%] | 36% [34–38%] |
IgA2-HCABD | 38% [34–42%] | 16% [14–18%] |